Sidley Austin, Freshfields and Morgan, Lewis & Bockius served as legal advisors to Cencora. Goodwin Procter and ReedSmith served as legal advisors to Retina Consultants of...
Cencora’s $5.1 Billion Acquisition of Retina Consultants of America
Capricor Therapeutics’ US$23 Million Common Stock Offering
Sidley represented Capricor Therapeutics, while Mintz, Levin, Cohn, Ferris, Glovsky, and Popeo represented Cantor Fitzgerald in the transaction. Capricor Therapeutics, Inc. has completed the issuance and...
Atia Vision’s Series E Financing
Sidley represented Atia Vision Inc. on the deal. Atia Vision Inc. announced its Series E financing led by Cormorant Asset Management with participation by The Capital Partnership,...
Denali’s US$236 Million Business Combination With Longevity Biomedical
Sidley advised Denali Capital Acquisition Corp., while Nelson Mullins Riley & Scarborough LLP assisted Longevity Biomedical. US Tiger Securities acted as business combination advisor to Denali. Denali...
Tyra Biosciences’ $172.8 Million Initial Public Offering
Latham & Watkins represented Tyra Biosciences in the offering while Sidley advised the underwriters. Tyra Biosciences, Inc. has announced the pricing of its upsized initial public offering of...
Attralus’ $116 Million Series B Financing
Wilson Sonsini Goodrich & Rosati advised Logos Capital on the deal while Sidley represented Attralus, Inc. Attralus, Inc., a clinical stage biopharmaceutical company developing transformative medicines...
Immuneering’s US$129.4 Million IPO
Sidley Austin advised the underwriters on the deal, while Choate and Latham & Watkins assisted Immuneering Corporation. Immuneering Corporation (Nasdaq: IMRX), a biopharmaceutical company advancing a...
Medline Industries’ US$286 Million Acquisition of Certain Respiratory Products from Teleflex
Sidley Austin LLP advised Medline Industries, Inc. on the deal. Medline announced its intentions to acquire a significant portion of the Hudson RCI® brand of respiratory...
Medline Industries’ US$286 Million Acquisition of Certain Respiratory Products from Teleflex
Sidley Austin LLP advised Medline Industries, Inc. on the deal. Medline announced its intentions to acquire a significant portion of the Hudson RCI® brand of respiratory...
LumiraDx Limited’s Merger Agreement with CA Healthcare Acquisition
Goodwin Procter, Fried Frank and Appleby advised LumiraDx Limited on the deal, while Sidley Austin LLP acted for CA Healthcare Acquisition Corp. LumiraDx Limited announced its...
Tempest Therapeutics’ Merger With Millendo Therapeutics
Sidley Austin LLP advised Tempest Therapeutics, Inc. on the deal. Tempest Therapeutics, Inc., a privately-held, clinical-stage oncology company developing potentially first-in-class therapeutics that combine both targeted...
Tempest Therapeutics’ Merger With Millendo Therapeutics
Sidley Austin LLP advised Tempest Therapeutics, Inc. on the deal. Tempest Therapeutics, Inc., a privately-held, clinical-stage oncology company developing potentially first-in-class therapeutics that combine both targeted...